EKSOEkso Bionics Holdings, Inc.

$29M

Q4 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5M+5.0% YoY

Gross Profit

$3M53.3% margin

Operating Income

-$2M-43.8% margin

Net Income

-$3M-67.1% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+23.3%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$387,000

Balance Sheet

Total Assets

$27M

Total Liabilities

$14M

Stockholders' Equity

$13M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$5M	+5.0%
Gross Profit	$3M	$2M	+14.6%
Operating Income	-$2M	-$3M	+35.3%
Net Income	-$3M	-$3M	-6.2%

Geographic Segments

Americas

$3M32%

UNITED STATES

$3M31%

EMEA

$2M20%

FRANCE

$1M11%

Americas Other

$371,0004%

Asia Pacific

$221,0002%

EKSO Q4 2024 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena